IRLAB Therapeutics
Developing novel drugs for Parkinson's disease and other neurodegenerative CNS disorders.
IRLAB | ST
Overview
Corporate Details
- ISIN(s):
- SE0012675361 (+1 more)
- LEI:
- 549300JAT34LHEI0DH60
- Country:
- Sweden
- Address:
- Arvid Wallgrens backe 20, 413 46 Göteborg
- Website:
- https://irlab.se/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
IRLAB Therapeutics is a drug discovery and development company specializing in novel treatments for neurodegenerative conditions, with a primary focus on Parkinson's disease and other Central Nervous System (CNS) disorders. The company's pipeline is generated by its proprietary research platform, the Integrative Screening Process (ISP), a systems pharmacology discovery method built on an extensive, unique database of CNS compounds. Key clinical-phase candidates include mesdopetam (IRL790), developed to treat levodopa-induced dyskinesia (LIDs), and pirepemat (IRL752), aimed at addressing impaired balance and falls associated with Parkinson's disease.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-20 16:40 |
Regulatory News Service
Valberedningen utsedd inför IRLAB:s årsstämma 2026
|
Swedish | 41.3 KB | ||
| 2025-11-20 16:40 |
Regulatory News Service
Nomination committee appointed for IRLAB’s annual general meeting 2026
|
English | 40.5 KB | ||
| 2025-10-29 07:00 |
Quarterly Report
|
Swedish | 577.5 KB | ||
| 2025-10-29 07:00 |
Quarterly Report
|
English | 571.8 KB | ||
| 2025-10-09 17:15 |
Board/Management Information
IRLAB utser Gustaf Albèrt till ny Chief Financial Officer
|
Swedish | 39.5 KB | ||
| 2025-10-09 17:15 |
Board/Management Information
IRLAB appoints Gustaf Albèrt as the new Chief Financial Officer.
|
English | 39.5 KB | ||
| 2025-08-29 07:00 |
Declaration of Voting Results & Voting Rights Announcements
Ändring av antalet aktier och röster i IRLAB Therapeutics AB
|
Swedish | 47.7 KB | ||
| 2025-08-29 07:00 |
Declaration of Voting Results & Voting Rights Announcements
Change in number of shares and votes in IRLAB Therapeutics AB
|
English | 47.0 KB | ||
| 2025-08-27 07:00 |
Interim Report
|
Swedish | 377.6 KB | ||
| 2025-08-27 07:00 |
Interim Report
|
English | 373.0 KB | ||
| 2025-08-21 11:00 |
Board/Management Information
IRLAB appoints Roy Jonebrant as interim CFO
|
English | 38.2 KB | ||
| 2025-08-21 11:00 |
Board/Management Information
IRLAB utser Roy Jonebrant till tillförordnad CFO
|
Swedish | 38.8 KB | ||
| 2025-08-11 09:00 |
Board/Management Information
IRLAB's CFO Viktor Siewertz leaves the company for a new leading position
|
English | 39.6 KB | ||
| 2025-08-11 09:00 |
Board/Management Information
IRLAB:s CFO Viktor Siewertz lämnar bolaget för ny ledande position
|
Swedish | 40.0 KB | ||
| 2025-07-18 18:31 |
Share Issue/Capital Change
IRLAB announces the outcome of the company’s rights issue
|
English | 64.4 KB |
Automate Your Workflow. Get a real-time feed of all IRLAB Therapeutics filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for IRLAB Therapeutics
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for IRLAB Therapeutics via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-08-05 | Kristina Torfgård | Other | Buy | 9,000 | 140,850.00 SEK |
| 2024-08-05 | Kristina Torfgård | Other | Buy | 4,500 | 70,875.00 SEK |
| 2024-05-14 | Gunnar Olof Olsson | Other | Buy | 2,000 | 31,000.00 SEK |
| 2024-05-10 | Daniel Johnsson | Other | Buy | 20,000 | 259,680.00 SEK |
| 2023-04-03 | Joakim Tedroff | Other | Buy | 51,430 | 2,038,685.20 SEK |
| 2022-09-01 | Richard Godfrey | Other | Buy | 5,000 | 174,457.00 SEK |
| 2022-08-30 | Viktor Siewertz | Other | Buy | 40 | 1,420.00 SEK |
| 2022-08-29 | Viktor Siewertz | Other | Sell | 40 | 1,408.00 SEK |
| 2022-07-15 | Joakim Tedroff | Other | Other | 84,148 | N/A |
| 2022-05-31 | Viktor Siewertz | Other | Buy | 4,500 | 170,370.00 SEK |
Peer Companies
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
